Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry.

Al-Makhamreh, Hanna; Al-Ani, Abdallah; Alkhulaifat, Dana; Shaban, Liza; Salah, Neveen; Almarayaty, Rusul; Al-Huneidy, Yazan; Hammoudeh, Ayman

Al-Makhamreh, Hanna; Al-Ani, Abdallah; Alkhulaifat, Dana; Shaban, Liza; Salah, Neveen; Almarayaty, Rusul; Al-Huneidy, Yazan; Hammoudeh, Ayman.

Afiliação

Al-Makhamreh H; Department of Internal Medicine, Division of Cardiology, Jordanian University Hospital, Amman, 11185, Jordan.
Al-Ani A; University of Jordan, School of Medicine, Amman, 11185, Jordan.
Alkhulaifat D; University of Jordan, School of Medicine, Amman, 11185, Jordan.
Shaban L; University of Jordan, School of Medicine, Amman, 11185, Jordan.
Salah N; University of Jordan, School of Medicine, Amman, 11185, Jordan.
Almarayaty R; University of Jordan, School of Medicine, Amman, 11185, Jordan.
Al-Huneidy Y; University of Jordan, School of Medicine, Amman, 11185, Jordan.
Hammoudeh A; University of Jordan, School of Medicine, Amman, 11185, Jordan.

Ann Med Surg (Lond) ; 74: 103325, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35145683

Palavras-chave

Anticoagulation; Atrial fibrillation; Middle east; Prevalence; Thyroid disorders

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Jordânia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google